Nick Gauthier - Rapid metagenomic next-generation sequencing for diagnosis of viral infections

Current viral diagnostic strategies are limited in that they rely on prior knowledge of a pathogen's genome. We are aiming to optimize, automate, and validate an agnostic Nanopore next-generation sequencing-based assay with host nucleic acid depletion for the detection and characterization of respiratory viral pathogens. We are completing analytical and clinical validation studies to assess the diagnostic performance of our assay for the detection of common respiratory pathogens (e.g. SARS-CoV-2, Flu A/B, RSV). The development and translation of this technology to clinical and public health laboratories will aid in public health response to emerging infectious diseases.

Mediasite Presenter

10/25/2022 6:05:00 PM